<?xml version="1.0"?>
<Articles JournalTitle="Acta Medica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>56</Volume>
      <Issue>7</Issue>
      <PubDate PubStatus="epublish">
        <Year>2018</Year>
        <Month>08</Month>
        <Day>13</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Acute Transplantation of Human Olfactory Mucosa-Derived Olfactory Ensheathing Cells Fails to Improve Locomotor Recovery in Rats</title>
    <FirstPage>421</FirstPage>
    <LastPage>428</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mina</FirstName>
        <LastName>Afhami</LastName>
        <affiliation locale="en_US">Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. AND Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mansoureh</FirstName>
        <LastName>Hashemi</LastName>
        <affiliation locale="en_US">Department of Neuroscience, Functional Neurosurgery Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Khashayar</FirstName>
        <LastName>Afshari</LastName>
        <affiliation locale="en_US">Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Jamal</FirstName>
        <LastName>Chenari</LastName>
        <affiliation locale="en_US">Department of Anatomical Sciences, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Mohammad</FirstName>
        <LastName>Tavangar</LastName>
        <affiliation locale="en_US">Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mahmoudreza</FirstName>
        <LastName>Hadjighassem</LastName>
        <affiliation locale="en_US">Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. AND Department of Neuroscience, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ahmad Reza</FirstName>
        <LastName>Dehpour</LastName>
        <affiliation locale="en_US">Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. AND Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ahad</FirstName>
        <LastName>Muhammadnejad</LastName>
        <affiliation locale="en_US">Cancer Biology Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Arvin</FirstName>
        <LastName>Haj-Mirzaian</LastName>
        <affiliation locale="en_US">Department of Pharmacology, Tehran University of Medical Sciences, Tehran, Iran. AND Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Vafa</FirstName>
        <LastName>Rahimi-Movaghar</LastName>
        <affiliation locale="en_US">Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. AND Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran. AND Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>10</Month>
        <Day>02</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>03</Month>
        <Day>13</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Olfactory ensheathing cells-based therapy for spinal cord injury (SCI) repair has been a possible treatment for clinical study because of their safety in autologous transplantation and potential regenerative capability. However, there are contradictory reports on the results after transplantation in animal models. The purpose of this research was to investigate the effect of acute transplantation of human mucosa-derived olfactory ensheathing cells (OECs) on the repair of the spinal cord. Human olfactory ensheathing cells were isolated from the human mucosa and cultured under supplemented neuronal cell culture medium. They were characterized by immunocytochemistry for olfactory ensheathing cell markers. We induced spinal cord injury at T8-T9 of rats by aneurysm clips and simultaneously injected two million OECs into subarachnoid space of spinal cord. Sensory and motor behaviors were recorded by tail-flick reflex (TFR) and BBB scores, respectively every week for seven weeks after injury. Morphology and S100-beta antigen expression in olfactory ensheathing cells of the human olfactory mucosa was confirmed by immunostaining. OECs transplantation did not recover inflammation, neuronal vacuolation, hemorrhage, and cyst formation. These findings suggest that OECs transplantation in this experimental setting did not lead to tissue regeneration to enhance locomotion. These results broaden current knowledge and are additions to the science and literature.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/6754</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/6754/5124</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>56</Volume>
      <Issue>7</Issue>
      <PubDate PubStatus="epublish">
        <Year>2018</Year>
        <Month>08</Month>
        <Day>13</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Mutation Analysis of ECM1 Gene in Two Related Iranian Patients Affected by Lipoid Proteinosis</title>
    <FirstPage>474</FirstPage>
    <LastPage>477</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Saeid</FirstName>
        <LastName>Morovvati</LastName>
        <affiliation locale="en_US">Human Genetic Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Paniz</FirstName>
        <LastName>Farshadyeganeh</LastName>
        <affiliation locale="en_US">School of Basic Sciences, Tehran Medical Branch, Islamic Azad University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mojdeh</FirstName>
        <LastName>Hamidizadeh</LastName>
        <affiliation locale="en_US">School of Basic Sciences, Islamic Azad University Tehran Medical Branch, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ziba</FirstName>
        <LastName>Morovvati</LastName>
        <affiliation locale="en_US">Department of Medical Genetics, Faculty of Advanced Medical Technologies, Golestan University of Medical Sciences, Gorgan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Samaneh</FirstName>
        <LastName>Doost Mohammadi</LastName>
        <affiliation locale="en_US">Faculty of Basic Sciences, Islamic Azad University of Zanjan, Zanjan, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>05</Month>
        <Day>17</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>18</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Lipoid proteinosis (LP) is a rare autosomal recessive disorder caused by malfunction mutations in extracellular matrix protein 1 gene (ECM1) with common features such as hoarseness of the voice, infiltration of the skin and mucosa, and varying degrees of skin scars. We studied two LP patients. Clinical and genetic examination and genetic counseling were carried out, and their family pedigree was drawn. Two different variants were found in exon 6 of ECM1 gene in both patients: a homozygous deletion of a nucleotide T at position 507 and a missense variant at nucleotide 389 which the first was a pathogenic mutation and the other one was a non-pathogenic variant.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/6466</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/6466/5131</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>56</Volume>
      <Issue>7</Issue>
      <PubDate PubStatus="epublish">
        <Year>2018</Year>
        <Month>08</Month>
        <Day>13</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">CXCR4 Is Important for Lymphopoiesis Not Only in Mice, but Also in Man</title>
    <FirstPage>482</FirstPage>
    <LastPage>483</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Hussein</FirstName>
        <LastName>Baharlooi</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Nima</FirstName>
        <LastName>Rezaei</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. AND Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran. AND Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ehsan</FirstName>
        <LastName>Sharif-Paghaleh</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. AND Division of Imaging and Biomedical Engineering, School of Life Sciences and Medicine, King&#x2019;s College London, London, United Kingdom.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>10</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>03</Month>
        <Day>02</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">No Abstract</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/6883</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/6883/5134</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>56</Volume>
      <Issue>7</Issue>
      <PubDate PubStatus="epublish">
        <Year>2018</Year>
        <Month>08</Month>
        <Day>13</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">The Pattern of Methylation and Polymorphism in Interleukin-6 Promoter Gene Are Related to the Development of Rheumatoid Arthritis?</title>
    <FirstPage>429</FirstPage>
    <LastPage>433</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Isaura Isabelle Fonseca</FirstName>
        <LastName>Gomes-Silva</LastName>
        <affiliation locale="en_US">Department of Genetics, Federal University of Pernambuco, Av. Prof. Moraes Rego, 1235-Cidade Universit&#xE1;ria, Recife-PE, Brazil.</affiliation>
      </Author>
      <Author>
        <FirstName>Eliezer</FirstName>
        <LastName>Rushansky</LastName>
        <affiliation locale="en_US">Department of Clinical Rheumatology, University of Pernambuco, Rua Arn&#xF3;bio Marques, 10-Santo Amaro, Recife-PE, Brazil.</affiliation>
      </Author>
      <Author>
        <FirstName>Francisco</FirstName>
        <LastName>Geraldo Carvalho-Neto</LastName>
        <affiliation locale="en_US">Department of Genetics, Federal University of Pernambuco, Av. Prof. Moraes Rego, 1235-Cidade Universit&#xE1;ria, Recife-PE, Brazil.</affiliation>
      </Author>
      <Author>
        <FirstName>Amanda</FirstName>
        <LastName>Virginia Batista Vieira</LastName>
        <affiliation locale="en_US">Department of Biology, Rural Federal University of Pernambuco, Rua Manoel de Medeiros-Dois Irm&#xE3;os, Recife-PE, Brazil.</affiliation>
      </Author>
      <Author>
        <FirstName>Maria</FirstName>
        <LastName>Helena Queiroz de Araujo Mariano</LastName>
        <affiliation locale="en_US">Department of Clinical Rheumatology, University of Pernambuco, Rua Arn&#xF3;bio Marques, 10-Santo Amaro, Recife-PE, Brazil.</affiliation>
      </Author>
      <Author>
        <FirstName>Paulo</FirstName>
        <LastName>Roberto Eleut&#xE9;rio de Souza</LastName>
        <affiliation locale="en_US">Department of Biology, Rural Federal University of Pernambuco, Rua Manoel de Medeiros-Dois Irm&#xE3;os, Recife-PE, Brazil.</affiliation>
      </Author>
      <Author>
        <FirstName>Mart&#xED;n</FirstName>
        <LastName>Alejandro Montes</LastName>
        <affiliation locale="en_US">Department of Biology, Rural Federal University of Pernambuco, Rua Manoel de Medeiros-Dois Irm&#xE3;os, Recife-PE, Brazil.</affiliation>
      </Author>
      <Author>
        <FirstName>Maria</FirstName>
        <LastName>Mascena Diniz Maia</LastName>
        <affiliation locale="en_US">Department of Biology, Rural Federal University of Pernambuco, Rua Manoel de Medeiros-Dois Irm&#xE3;os, Recife-PE, Brazil.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>04</Month>
        <Day>08</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>12</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Rheumatoid Arthritis (RA) is a complex disease with higher level of IL-6. In order to elucidate the alterations related to IL-6 gene in RA, we evaluated the -174 G/C IL-6 gene polymorphism and methylation pattern of its promoter. A total of 120 RA patients and 120 healthy controls were recruited for polymorphism analysis, and 30 individuals of both groups were randomly selected for methylation analysis. The IL-6 gene polymorphism was analyzed by PCR-RFLP and methylation pattern was analyzed by MSP-PCR. Regarding IL-6 gene polymorphism, no significant difference was found between RA patients and controls (P&gt;0.05). For DNA, two CpG regions of IL-6 promoter gene was analyzed. The first region (&#x2212;1069, &#x2212;1061, &#x2212;1057 and &#x2212;1001 CpG) did not show significant differences, whereas the second region (&#x2212;628, &#x2212;610, &#x2212;574 and &#x2212;491 CpG) showed a significant hypermethylated status (P=0.0004) in RA patients as compared with controls.These results, suggest a possible relationship between methylation pattern and the susceptibility to RA in our studied population.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/6344</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/6344/5125</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>56</Volume>
      <Issue>7</Issue>
      <PubDate PubStatus="epublish">
        <Year>2018</Year>
        <Month>08</Month>
        <Day>13</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Persistent Low Levels of Beta-hCG: A Pitfall in Diagnosis of Retained Product of Conception</title>
    <FirstPage>478</FirstPage>
    <LastPage>481</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Leila</FirstName>
        <LastName>Pourali</LastName>
        <affiliation locale="en_US">Department of Obstetrics and Gynecology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Sedigheh</FirstName>
        <LastName>Ayati</LastName>
        <affiliation locale="en_US">Department of Obstetrics and Gynecology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Parvaneh</FirstName>
        <LastName>Layegh</LastName>
        <affiliation locale="en_US">Department of Radiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Atieh</FirstName>
        <LastName>Vatanchi</LastName>
        <affiliation locale="en_US">Department of Obstetrics and Gynecology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Rastin</LastName>
        <affiliation locale="en_US">Department of Obstetrics and Gynecology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Azadeh</FirstName>
        <LastName>Shourvi</LastName>
        <affiliation locale="en_US">Department of Obstetrics and Gynecology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>07</Month>
        <Day>09</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>18</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Persistent low level of beta-hCG (PLL) is defined as rising hCG level no more than two-fold over a three months period. Almost many types of PLL can lead to the wrong diagnosis. Here, we presented two cases of the retained product of conception (RPOC) with persistent low levels of beta-hCG. Both cases were presented with persistent low levels of beta-hCG and abnormal uterine bleeding since first-trimester pregnancy termination. Ultrasonography revealed a vascular mass with extension from the endometrial cavity to myometrium imitating gestational trophoblastic disease (GTD) or arteriovenous malformation (AVM). The final pathologies of both cases were retained product of conception. Imaging features of RPOC can closely imitate those of an AVM or GTN; so, hysteroscopy is one of the best non-invasive procedures which may be helpful in diagnosis and selection of appropriate treatment especially in young patients who desire to preserve their fertility.
&#xA0;</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/6589</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/6589/5133</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>56</Volume>
      <Issue>7</Issue>
      <PubDate PubStatus="epublish">
        <Year>2018</Year>
        <Month>08</Month>
        <Day>13</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Detection and Genotyping of Epstein-Bar Virus Among Paraffin Embedded Tissues of Hodgkin and Non-Hodgkin's Lymphoma Patients in Ahvaz, Iran</title>
    <FirstPage>434</FirstPage>
    <LastPage>440</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Ala</FirstName>
        <LastName>Habibian</LastName>
        <affiliation locale="en_US">Infectious and Tropical Diseases Research Center, Health Research Institute, Jundishapur University of Medical Sciences, Ahvaz, Iran. AND  Department of Virology, Jundishapur University of Medical Sciences, Ahvaz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Manoochehr</FirstName>
        <LastName>Makvandi</LastName>
        <affiliation locale="en_US">Infectious and Tropical Diseases Research Center, Health Research Institute, Jundishapur University of Medical Sciences, Ahvaz, Iran. AND  Department of Virology, Jundishapur University of Medical Sciences, Ahvaz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Samarbaf-Zadeh</LastName>
        <affiliation locale="en_US">Infectious and Tropical Diseases Research Center, Health Research Institute, Jundishapur University of Medical Sciences, Ahvaz, Iran. AND  Department of Virology, Jundishapur University of Medical Sciences, Ahvaz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Niloofar</FirstName>
        <LastName>Neisi</LastName>
        <affiliation locale="en_US">Research Center, Health Research Institute, Jundishapur University of Medical Sciences, Ahvaz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Rahim</FirstName>
        <LastName>Soleimani-Jelodar</LastName>
        <affiliation locale="en_US">Infectious and Tropical Diseases Research Center, Health Research Institute, Jundishapur University of Medical Sciences, Ahvaz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Kamyar</FirstName>
        <LastName>Makvandi</LastName>
        <affiliation locale="en_US">Department of Orthopedic Surgery, Taleghani Hospital Research Development Unit, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Shima</FirstName>
        <LastName>Izadi</LastName>
        <affiliation locale="en_US">Infectious and Tropical Diseases Research Center, Health Research Institute, Jundishapur University of Medical Sciences, Ahvaz, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>07</Month>
        <Day>16</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>18</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Epstein-Barr virus (EBV) is a DNA virus which belongs to the Herpesviridae family, has been infected with 90% of the world&#x2019;s population. EBV is transmitted through saliva and associated with different diseases such as Infectious Mononucleosis, Nasopharyngeal Carcinoma, Burkitt`s lymphoma, Hodgkin and Non-Hodgkin`s lymphoma. This study was designed to determine the frequency of EBV DNA and genotyping of this virus in histological tissues of Hodgkin and Non-Hodgkin's lymphoma in Ahvaz, Iran. In this study, 12 samples of Hodgkin and 29 samples of Non-Hodgkin`s lymphoma were examined from Ahvaz Imam Khomeini Hospital. After deparaffinization and DNA extraction, Nested-PCR technique was carried out on Epstein-Barr nuclear antigen 1 (EBNA-1) and Epstein-Barr nuclear antigen 3C (EBNA-3C) regions in order to detect EBV genome and genotype in tumoral tissues. Among 12 cases of Hodgkin`s lymphoma, 3 (25%) cases and among 29 cases of Non-Hodgkin's lymphoma, 14 (48%) cases were positive for EBV. All 3 EBV positive cases of Hodgkin`s lymphoma and a number of 8 (57%) cases of Non-Hodgkin`s lymphoma belonged to the adolescence age group which proves an association between age and EBV positive in Hodgkin and Non-Hodgkin`s lymphoma according to Fisher`s exact test (P=0.03). All EBV positive cases in Hodgkin and Non-Hodgkin`s lymphoma were EBV-1. The results of this study revealed that EBV played a possible important role in Hodgkin and Non-Hodgan University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Moloud</FirstName>
        <LastName>Payab</LastName>
        <affiliation locale="en_US">Obesity and Eating Habits Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Gholamreza</FirstName>
        <LastName>Pourmand</LastName>
        <affiliation locale="en_US">Urology Research Center, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>03</Month>
        <Day>13</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Stress urinary incontinence is a common medical problem among women. The urethral closure complex and/or the supportive mechanisms are responsible for incontinence in the majority of patients. Several surgical procedures with different degrees of invasiveness and outcomes have been reported to treat the problem. Although most of these procedures are reasonably effective, a general trend towards the study of natural and biocompatible tissues is emerging over popular synthetic materials. Here we report our experience of autologous adipose-derived stem cells transplantation into the periurethral region as a new method of stress urinary incontinence treatment. Ten women with symptoms of stress urinary incontinence were treated by injections of autologous adipose-derived stem cells into the periurethral region via transurethral and transvaginal approach under urethroscopic observation. This report presents the short-term outcome of the patients. The outcome measured by pad test results, ICIQ-SF scores, and Qmax. The mean age of the participants was 45.8&#xB1;8.7 years. Urinary incontinence significantly decreased through the first two, 6 and 24 weeks after the injection therapy. The difference was significant in pad test results (P&lt;0.001) and ICIQ-SF scores (P&lt;0.001), especially comparing results between 2 and 6 weeks and among 6 and 24 weeks, but not for 2 and 6 weeks compared to each other. Surprisingly, Qmax showed improvement after the study period (means 32.6 vs. 35.7; P=0.002). This study showed that injection of the autologous adipose-derived stem cells to the periurethral region is a safe, yet short-term effective treatment option for stress urinary incontinence. Further studies with longer follow up are needed to confirm its long term efficacy.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/6295</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/6295/4947</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>55</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>08</Month>
        <Day>19</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">An Uncommon Complication of Streptokinase: Large Spontaneous Iliopsoas Hematoma</title>
    <FirstPage>411</FirstPage>
    <LastPage>413</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Raheleh</FirstName>
        <LastName>Aliabadi</LastName>
        <affiliation locale="en_US">Rasoul-e-Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hassan</FirstName>
        <LastName>Riahi Beni</LastName>
        <affiliation locale="en_US">Rasoul-e-Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Jila</FirstName>
        <LastName>Nadjafi</LastName>
        <affiliation locale="en_US">East Surrey Associate Hospital for Brighton University, London, Uk.</affiliation>
      </Author>
      <Author>
        <FirstName>Morteza</FirstName>
        <LastName>Hassanzade</LastName>
        <affiliation locale="en_US">Rasoul-e-Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mehrnaz</FirstName>
        <LastName>Tabrizi</LastName>
        <affiliation locale="en_US">Rasoul-e-Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohsen</FirstName>
        <LastName>Nasiri</LastName>
        <affiliation locale="en_US">Rasoul-e-Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Gandom</FirstName>
        <LastName>Sedehi</LastName>
        <affiliation locale="en_US">Rasoul-e-Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Pourmojarab</LastName>
        <affiliation locale="en_US">Rasoul-e-Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>28</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2016</Year>
        <Month>04</Month>
        <Day>17</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Streptokinase is a fibrinolytic agent that enhances plasmin activation and is used in selected patients with acute ST elevation myocardial infarction (STEMI). Similar to the other thrombolytics, a common side effect is bleeding, especially from venous puncture sites. Here, we present a case of acute anterior wall STEMI complicated by large spontaneous iliopsoas hematoma after streptokinase administration. With conservative management, the course of the disease was uneventful, and the patient was discharged with no symptom and no clinically important sequel.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/5087</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/5087/4955</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>55</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>08</Month>
        <Day>19</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Assessment of the Prevalence and Risk Factors Associated With Glucocorticoid-Induced Diabetes Mellitus in Pemphigus Vulgaris Patients</title>
    <FirstPage>375</FirstPage>
    <LastPage>380</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Abbas</FirstName>
        <LastName>Darjani</LastName>
        <affiliation locale="en_US">Department of Dermatology, Skin Research Center, Guilan University of Medical Sciences, Rasht, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Nahid</FirstName>
        <LastName>Nickhah</LastName>
        <affiliation locale="en_US">Department of Dermatology, Skin Research Center, Guilan University of Medical Sciences, Rasht, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Hassan</FirstName>
        <LastName>Hedayati Emami</LastName>
        <affiliation locale="en_US">Department of Internal Medicine, Endocrinology and Metabolism Research Center, Guilan University of Medical Sciences, Rasht, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Narges</FirstName>
        <LastName>Alizadeh</LastName>
        <affiliation locale="en_US">Department of Dermatology, Skin Research Center, Guilan University of Medical Sciences, Rasht, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Rana</FirstName>
        <LastName>Rafiei</LastName>
        <affiliation locale="en_US">Department of Dermatology, Skin Research Center, Guilan University of Medical Sciences, Rasht, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hojat</FirstName>
        <LastName>Eftekhari</LastName>
        <affiliation locale="en_US">Department of Dermatology, Skin Research Center, Guilan University of Medical Sciences, Rasht, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Kaveh</FirstName>
        <LastName>Gharaei Nejad</LastName>
        <affiliation locale="en_US">Department of Dermatology, Skin Research Center, Guilan University of Medical Sciences, Rasht, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>04</Month>
        <Day>07</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>02</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Pemphigus vulgaris is a chronic autoimmune disease and glucocorticoids are one of the main treatments. Our study investigates the prevalence and associated factors of glucocorticoid-induced diabetes mellitus in these patients under different glucocorticoid regimens. 36 patients with first diagnosed Pemphigus vulgaris based on pathological and direct immunofluorescence findings who had received different glucocorticoid regimens (1-2 mg/kg oral or 1-2 mg/kg oral with 1g methylprednisolone pulse daily for 3 consecutive days with or without azathioprine) were evaluated during 2014-2016. Our study found that 22.2% of patients had impaired fasting glucose and incidence of corticosteroid-induced diabetes mellitus was 22.2% with no difference between oral and pulse therapy of corticosteroid. The first day after pulse therapy 19 patients of 21 had post bolus hyperglycemia that 36% of them became diabetic after 8 weeks. None of the variables, including age, BMI, HbA1c, LDL, HDL, TG, cholesterol, family history and blood pressure were associated with diabetes. Pretreatment FBS was the factor that would increase the likelihood of glucocorticoid-induced diabetes mellitus, 42.2% of patients with pretreatment FBS 100-126 developed diabetes in comparison with 17.2% in normal pretreatment FBS. Although the group who received azathioprine was associated with increased incidence of diabetes, the overall corticosteroid dose in this group was significantly higher than the other group (P=0.012), and controversy with other studies could be because of difference in corticosteroid dosage and small number of patients. The incidence of diabetes was not different between the group with glucocorticoid pulses and oral prednisolone without pulse therapy. Higher pretreatment FBS can be related to increased incidence of diabetes, but results from this study due to small number of patients are preliminary and multicenter studies are needed.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/5561</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/5561/4948</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>55</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>08</Month>
        <Day>19</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Evaluation of Cognitive Functions in Iranian Children and Adolescents With Diabetes Mellitus</title>
    <FirstPage>381</FirstPage>
    <LastPage>388</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Ata</FirstName>
        <LastName>Pourabbasi</LastName>
        <affiliation locale="en_US">Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mehdi</FirstName>
        <LastName>Tehrani-Doost</LastName>
        <affiliation locale="en_US">Department of Psychiatry, Rouzbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Soqra</FirstName>
        <LastName>Ebrahimi Qavam</LastName>
        <affiliation locale="en_US">Department of Educational Psychology, Faculty of Psychology and Education, Allameh Tabataba&#x2019;ee University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Jalal</FirstName>
        <LastName>Farzami</LastName>
        <affiliation locale="en_US">Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modarres University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Bagher</FirstName>
        <LastName>Larijani</LastName>
        <affiliation locale="en_US">Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>01</Month>
        <Day>31</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>02</Month>
        <Day>07</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Diabetes in children and adolescents is a chronic condition with an expanding trend in the community. Several studies have shown cognitive dysfunctions are the most important side effects of diabetes among individuals of younger ages. Due to cultural differences and their impact on cognitive issues, the authors decided to assess the cognitive functions of Iranian children and adolescents with diabetes. Cognitive functions including memory, attention and executive functions were evaluated in 62 diabetic children and adolescents and healthy peers using CANTAB cognitive tests. Other data such as demographic, school performance and medical information were collected by questionnaires. Except in the case of few variables in RVP, SSP and SST, no significant difference exists between diabetic children and the control group in terms of different cognitive domains. But cognitive variables, especially in PRM, SWM and SOC test, has been shown to be deteriorated with increasing HbA1C values in serum levels. Diabetes has no impact on the cognitive functioning of children provided by maintaining a glycemic control. It is proposed that the adoption of appropriate parenting styles and family and social support can prevent cognitive changes in children with diabetes.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/6197</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/6197/4949</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>55</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>08</Month>
        <Day>19</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Smoking Discriminately Changes the Serum Active and Non-Active Forms of Vitamin B12</title>
    <FirstPage>389</FirstPage>
    <LastPage>394</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Niloofar</FirstName>
        <LastName>Shekoohi</LastName>
        <affiliation locale="en_US">Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Hassan</FirstName>
        <LastName>Javanbakht</LastName>
        <affiliation locale="en_US">Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Marjan</FirstName>
        <LastName>Sohrabi</LastName>
        <affiliation locale="en_US">Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mahnaz</FirstName>
        <LastName>Zarei</LastName>
        <affiliation locale="en_US">Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hamed</FirstName>
        <LastName>Mohammadi</LastName>
        <affiliation locale="en_US">Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mahmoud</FirstName>
        <LastName>Djalali</LastName>
        <affiliation locale="en_US">Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>05</Month>
        <Day>20</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>02</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Smoking may modify the appetite, and consequently affect nutrient intake and serum micronutrients. The effect of smoking on vitamin B12 status has been considered in several studies. The research proposed that organic nitrites, nitro oxide, cyanides, and isocyanides of cigarette smoke interfere with vitamin B12 metabolism, and convert it to inactive forms. This research was carried out to determine the serum level of active and inactive forms of vitamin B12 in male smokers in comparison with male nonsmokers. This is a case-control study, in which the participants were 85 male smokers and 85 male nonsmokers. The serum levels of total and active form of vitamin B12 were measured. Dietary intake was recorded by a quantitative food frequency questionnaire and one-day 24-hour dietary recall method. Independent two sample T test was used to compare quantitative variables between the case and control groups. The serum level of total vitamin B12 was not significantly different between two groups, but serum level of active form of vitamin B12 in the smoking group was significantly lower than non-smoking group (P&lt;0.001). This is one of the first studies that evaluated the serum level of active form of vitamin B12 in smokers in the Iranian community. The results of this study identified that serum level of total vitamin B12 might be not different between smoking and non-smoking people, but the function of this vitamin is disturbed in the body of smokers through the reduction of serum level of active form of vitamin B12.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/5648</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/5648/4950</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>55</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>08</Month>
        <Day>19</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Does Adding Intravenous Phosphorus to Parenteral Nutritio